Physiological intervention by Cyp1b1 deletion occurs through removal of estradiol and generation of hydroxyl products, which variously target nuclear (ERα, ERβ) and membrane associated receptors (ERα, GPER), and affects an increasing number of processes, including blood pressure and cancer [41] and tryptophan dimerization products [42]. The gene discussed is GPER1; the disease is cancer.